The long-term health risks of using semaglutide are still being researched
FDA safety concerns The FDA has been vocal about safety concerns regarding compounded GLP-1 medications
Lundberg JO, Gladwin MT, Weitzberg E
By harnessing the synergies between lifestyle modifications and pharmacological interventions, healthcare providers can tailor treatment plans to individual needs, maximizing effectiveness and empowering individuals to reclaim their health and well-being
Twin is already trusted by leading employers to treat cardiometabolic disease without long-term dependence on high-cost medications: At Medline, we focus on long-term metabolic health by addressing root causes like insulin resistance, inflammation, and overall cardiometabolic risk, said Angela Sim, Vice President of Benefits at Medline